Northpond Ventures, LP

Holdings History for Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO)

Symbol: MREO on Nasdaq
Investment type: Equity / Ordinary Shares, par value GBP 0.003 per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Northpond Ventures, LP ownership in Mereo BioPharma Group plc Ordinary Shares, par value GBP 0.003 per share (MREO)

17 Feb 2026 - Northpond Ventures, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Mereo BioPharma Group plc Ordinary Shares, par value GBP 0.003 per share (MREO). This represents 0% ownership of the company. In their previous filing dated 11 Jun 2025, Northpond Ventures, LP had reported owning 54,521,000 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Northpond Ventures, LP	0%	-99%	$0	0	-54,521,000	-100%	$0.66	13G/A	31 Dec 2025	17 Feb 2026, 18:49
Michael P. Rubin	6.9%		$136,302,500	54,521,000			$2.50	13G	04 Jun 2025	11 Jun 2025, 19:51